Concentrix Affirms FY2026 Adj EPS Guidance of $11.48-$12.07 vs $11.87 Est; Affirms FY2026 Sales Guidance of $10.035B-$10.180B vs $10.132B Est

Benzinga Newsdesk www.benzinga.com Negative 51.9%

Neg 51.9% Neu 0% Pos 0%

Concentrix (NASDAQ:CNXC) affirms FY2026 Adj EPS guidance from $11.48-$12.07 to $11.48-$12.07 vs $11.87 analyst estimate. Affirms FY2026 sales outlook from $10.035 billion-$10.180 billion to $10.035 billion-$10.180 billion vs $10.132 billion estimate.